The invention relates to methods and devices for conducting multiplex assays for determining absorption, distribution, metabolism, and/or excretion (ADME) properties of an analyte. The method and device provide the ability to study analytes by controllably flowing, in laminar flow, an analyte in an analyte stream over a substrate having a plurality of substantially parallel individual test lanes on the surface thereof, wherein each test lane comprises a plurality of living cells immobilized therein. Changes, when present, in the analyte, the cells, or both, are detected and thereafter correlated to an ADME property of the analyte.
Formulation And Dosage Form For Increasing Oral Bioavailability Of Hydrophilic Macromolecules
Liang Dong - Sunnyvale CA, US Patrick Wong - Burlingame CA, US Vu Nguyen - San Jose CA, US Si-Hong Yum - Belmont CA, US Anthony Chao - Cupertino CA, US Peter Daddona - Menlo Park CA, US
The present invention includes a formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules. The formulation of the present invention includes a permeation enhancer, a hydrophilic macromolecule, and a carrier that exhibits in-situ gelling properties, such as a nonionic surfactant. The formulation of the present invention is delivered within the GI tract as a liquid having at least some affinity for the surface of the GI mucosal membrane. Once released, it is believed that the liquid formulation spreads across one or more areas of the surface of the GI mucosal membrane, where the carrier of the formulation then transitions into a bioadhesive gel in-situ. As a bioadhesive gel, the formulation of the present invention presents the hydrophilic macromolecule and the permeation enhancer at the surface of the GI mucosal membrane at concentrations sufficient to increase absorption of the hydrophilic macromolecule through the GI mucosal membrane over a period of time. The dosage form of the present invention incorporates the formulation of the present invention and may be designed to provide the controlled release of the formulation within the GI tract over a desired period of time.
Method And System For Data Capture With Hidden Applets
Matthias Chang - New York NY, US Hok Wong - Hartsdale NY, US Anthony Chao - New York NY, US Mark Graham - Scarsdale NY, US
International Classification:
G09G005/00
US Classification:
345/760000, 345/749000
Abstract:
A method and system for data display and data capture using applets within hidden frames on a browser. A visible frame and two invisible frames are passed to a client in response to an http request. The visible frame may include multiple layers. The hidden frames contain applets such as Java Server programs (JSP), but do not contain any visible html. Static data that is used for data display and data selection (e.g. pick boxes) is contained within one hidden frame. An applet, such as JSP within the other hidden frame provides an interface between the visible frame and the server to retrieve dynamic data, or verify data entry.
Formulation And Dosage Form For Increasing Oral Bioavailability Of Hydrophilic Macromolecules
Liang C. DONG - Sunnyvale CA, US Patrick S. L. WONG - Burlingame CA, US Vu A. NGUYEN - San Jose CA, US Si-Hong Alicia Yum - Belmont CA, US Anthony C. CHAO - Cupertino CA, US Peter E. Daddona - Menlo Park CA, US
A formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules includes a permeation enhancer, a hydrophilic macromolecule, and a carrier such as a nonionic surfactant that exhibits in-situ gelling properties. The formulation is delivered within the GI tract as a liquid having at least some affinity for the surface of the GI mucosal membrane. Once released, it is believed that the liquid formulation spreads across one or more areas of the surface of the GI mucosal membrane, where the carrier of the formulation then transitions into a bioadhesive gel in-situ. As a bioadhesive gel, the formulation presents the hydrophilic macromolecule and the permeation enhancer at the surface of the GI mucosal membrane at concentrations sufficient to increase absorption of the hydrophilic macromolecule through the GI mucosal membrane over a period of time. A dosage form incorporates the formulation and may be designed to provide the controlled release of the formulation within the GI tract over a desired period of time.